In an interview published on 26 February 2026, Vitalant describes the evolution of its Cayman captive and the possibility of changing retentions, limits and financing arrangements. The portfolio has expanded to include medical stop-loss and employment-related exposures, providing a concrete connection between captive strategy and employee benefits.
The interview makes an important distinction about reinsurance: it is being considered, but is not yet in place in the account reviewed. Possible future arrangements should not be reported as completed purchases. The source is a first-hand organisational case, not evidence of market-wide performance or a benchmark for another employer.
Review the combined portfolio For benefits and risk teams, adding medical stop-loss to a captive creates a reason to examine the whole portfolio. Management should explain the relationship between individual coverage decisions and the overall financing capacity. A board needs enough information to understand how a proposed change affects the organisation, rather than evaluating each coverage in isolation.
The assessment should distinguish an existing exposure from a proposal to retain more risk. Terms, assumptions and the evidence supporting a decision need to be explicit. A difficult commercial placement can explain why a captive option is being examined, but it does not establish that every alternative retention is affordable or appropriate.
Keep plans separate from execution When reinsurance is under consideration, a board paper should identify the decision still to be made and the conditions that would support it. Comparisons need to account for the risks transferred and the remaining obligations. General observations about market pricing cannot determine the economics of an individual programme.
The same discipline applies to coverage expansion. Management should describe the proposed scope and show how the organisation would administer it. Employees and other stakeholders should not be told that a financing proposal has changed their protection before the applicable arrangements are established.
Preserve accountable oversight This editor recommends using Vitalant’s case to examine how captive growth is supported by controls and clear responsibilities. Parent-board participation can strengthen the connection to the organisation’s objectives, but it does not itself demonstrate independent scrutiny. Independent directors should have access to the assumptions and potential conflicts behind a material decision.
The case illustrates a captive adapting to its parent’s needs over time. Its practical lesson is a process: distinguish what exists, what is proposed and what evidence the board requires before authorising the next change.
Share this:
- More [2]
